Литература
1. Демоскоп weekly: электронная версия бюллетеня «Население и общество». Available at:
http://demoscope.ru/weekly/2013/0543/barom02.php.
2. Chan A.O., Jim M.H., Lam K.F., Morris J.S., Siu D.C., Tong T. et al. Prevalence of colorectal neoplasm among patients with newly diagnosed coronary
artery disease. JAMA. 2007; 298 (12): 1412–9.
3. Neugut A.I., Rosenberg D.J., Ahsan H., Jacobson J.S., Wahid N., Hagan M. et al. Association between coronary heart disease and cancers of the breast,
prostate, and colon. Cancer Epidemiol. Biomarkers Prev. 1998; 7 (10): 869–73.
4. Reicher-Reiss H., Jonas M., Goldbourt U., Boyko V., Modan B. Selectively increased risk of cancer in men with coronary heart disease. Am. J. Cardiol.
2001; 87 (4): 459–62.
5. Zöller B., Ji J., Sundquist J., Sundquist K. Risk of haemorrhagic and ischaemic stroke in patients with cancer: a nationwide follow-up study from
Sweden. Eur. J. Cancer. 2012; 48 (12): 1875–83.
6. Cooke N.M., Egan K., McFadden S., Grogan L., Breathnach O.S., O’Leary J. et al. Increased platelet reactivity in patients with late-stage metastatic
cancer. Cancer Med. 2013; 2 (4): 564–70.
7. Trip M.D., Cats V.M., van Capelle F.J., Vreeken J. Platelet hyperreactivity and prognosis in survivors of myocardial infarction. N. Engl. J. Med. 1990;
322 (22): 1549–54.
8. Caine G.J., Stonelake P.S., Lip G.Y., Kehoe S.T. The hypercoagulable state of malignancy: pathogenesis and current debate. Neoplasia. 2002; 4 (6):
465–73.
9. Mercadante S., Gebbia V., Marrazzo A., Filosto S. Anemia in cancer: pathophysiology and treatment. Cancer Treat. Rev. 2000; 26 (4): 303–11.
10. Lipgic E., Asselbergs F.W., van der Meer P., Tio R.A., Voors A.A., van Gilst W.H. et al. Anaemia predicts cardiovascular events in patients with stable
coronary artery disease. Neth. Heart J. 2005; 13 (7–8): 254–8.
11. Важенин A.B., Фокин А.А., Лукин А.А. Диагностика и лечение сопутствующих злокачественных новообразований, атеросклеротичес-
кой стенозирующей аортоартериальной патологии и отдаленных лучевых повреждений магистральных артерий. В кн.: Материалы VI
Ежегодной Российской онкологической конференции. 26–28 ноября 2002 г., Москва. М.; 2002.
12. Hansen E.S. Shared risk factors for cancer and atherosclerosis (a review of the epidemiological evidence). Mutat Res. 1990; 239 (3): 163–79.
13. Libby P. Inflammation in atherosclerosis. Arterioscler. Thromb. Vasc. Biol. 2012; 32 (9): 2045–51.
14. Coussens L.M., Werb Z. Inflammation and cancer. Nature. 2002; 420 (6917): 860–7.
15. Garfinkel L. Overweight and cancer. Ann. Int. Med. 1985; 103 (6): 1034–6.
16. Britton K.A., Massaro J.M., Murabito J.M., Kreger B.E., Hoffmann U., Fox C.S. Body fat distribution, incident cardiovascular disease, cancer, and allcause
mortality. J. Am. Coll. Cardiol. 2013; 62 (10): 921–5.
17. Gyenes G., Fomander T., Carlens P., Glas U., Rutqvist L.E. Myocardial damage in breast cancer patients treated with adjuvant radiotherapy: a prospective
study. Int. J. Radiat. Oncol. Biol. Phys. 1996; 36 (4): 899–905.
18. Girinsky T., Cosset J.M. Pulmonary and cardiac late effects of ionizing radiations alone or combined with chemotherapy. Cancer Radiother. 1997; 1
(6): 735–43.
19. Marks L.B., Yu X., Prosnitz R.G., Zhou S.M., Hardenbergh P.H., Blazing M. et al. The incidence and functional consequences of RT-associated cardiac
perfusion defects. Int. J. Radiat. Oncol. Biol. Phys. 2005; 63 (1): 214–23.
20. Godina C., Maccagni D., Pavon A.G., Viani G., Cappelletti A., Margonato A. et al. Estimating organs cancer incidence related to patient radiation exposure
following PCI for acute and chronic coronary total occlusion. J. Invasive Cardiol. 2013; 25 (9): 441–5.
